A finalist in UNMC’s search for the new director of the Fred & Pamela Buffett Cancer Center and the Eppley Institute for Research in Cancer will be on campus Thursday, July 27.
Faculty, staff and students are invited to hear from Kathleen Moore, MD, the Virginia Kerley Cade Chair in Developmental Therapeutics at the Stephenson Cancer Center/University of Oklahoma Health Sciences Center, during an open campus forum Thursday. The forum will be from noon to 12:45 p.m. in in the Fred & Pamela Buffett Cancer Center, Room 0.12101, and also will be available via Zoom. Attendees can access the Zoom link via this intranet page and ask questions during the forum.
Dr. Moore also serves as associate director of clinical research, director of the TSET/SCRI Phase I Drug Development Unit and director of the Clinical Trials Office. She is highly regarded for her expertise in gynecologic malignancies and her significant contributions to drug development; her leadership spans national and international clinical trials, ranging from phase 1 to phase 3 studies.
Notably, she led the team that conducted the pivotal SOLO-1 clinical trial, resulting in the global approval of Olaparib as a frontline treatment for BRCA-mutated ovarian cancer. In addition, she played a critical role in the successful administration and presentation of the pivotal phase 3 trial, MIRASOL, which evaluated the efficacy of Mirvetuximab soravtansine (formerly known as IMGN853) at the 2023 ASCO conference.
Committed to the growth and development of young trialists, Dr. Moore serves as a mentor to multiple recipients of Wynn Diversity in Cancer Research grants and NRG Scholars. She also offers guidance and support to medical and gynecologic oncologists across the nation.
Find candidate bios and the dates/times for each campus presentation at this link. Candidates will be added to the site as they are introduced to the UNMC community.
During each campus visit, candidates will meet with campus and community stakeholders, as well as participate in an open campus presentation, in which they will make an introduction to the UNMC community, share their vision for the cancer center and institute and answer questions from participants.
Zoom links for each candidate’s presentation will be available via the finalist intranet page; links will be added on the day of their visit.
Provide feedback on Dr. Moore’s presentation via a confidential survey form that will be added to the search webpage as finalists are introduced to the UNMC community.
The candidate selected will succeed Ken Cowan, MD, PhD, who will step down from his roles but remain a full-time faculty member and continue to see patients. Dr. Cowan joined the medical center in 1999 and, in 2021, led the Fred & Pamela Buffett Cancer Center to a successful renewal of its National Cancer Institute Cancer Center Support Grant.